Share
Trueinvivo exhibited (and attended) the International Conference on Dosimetry and its Applications (ICDA-2) at the University of Surrey from 3rd to 8th July 2016. There was great interest in the micro silica beads and their potential use. The company also made very good international connections and is in the process of signing a Memorandum of Understanding (MOU) with another organisation.
Related Posts
TRUEinvivo's 2018 achievements include prototype development, patent filings, fundraising, multiple awards, and market expansion, setting the stage for a busy 2019.
TRUEinvivo wins Business Innovation of the Year Award for DOSEmapper™ technology, revolutionizing radiotherapy safety.
Mount Vernon Cancer Centre pioneers first internal invivo dosimetry with TRUEnvivo® DOSEmapper™, revolutionising radiotherapy precision, patient safety, and treatment accuracy.
TRUEinvivo named finalist in Surrey Business Awards for Business Innovation of the Year, recognizing DOSEmapper™ technology
